Recombinant Human Interferon α-2b Spray
It is the first Interferon spray in the world, indicated for the
treatment of primary and recurrence oral and genital herpes simplex
and condyloma accuminatum.
With the advanced technology of protein transdermal drug delivery
systems and non-contact quantitative spray, Interferon binds to mucous
cell-surface receptors to inhibit virus replication directly, which
frees the patient suffering from pain of injection or embrocate
administration and avoids cross-infection as well.
Jaferon Spray is special for its convenience, prompt effect, safety
and sanitation, no obvious adverse reactions.